Cell and Neurobiology, Keck School of Medicine of USC, 1333 San Pablo St., Los Angeles, CA 90033.
Am J Physiol Renal Physiol. 2013 Aug 15;305(4):F510-9. doi: 10.1152/ajprenal.00183.2013. Epub 2013 May 29.
During angiotensin II (ANG II)-dependent hypertension, ANG II stimulates, while hypertension inhibits, Na(+) transporter activity to balance Na(+) output to input. This study tests the hypothesis that ANG II infusion activates Na(+) transporters in the distal nephron while inhibiting transporters along the proximal nephron. Male Sprague-Dawley rats were infused with ANG II (400 ng·kg(-1)·min(-1)) or vehicle for 2 wk. Kidneys were dissected (cortex vs. medulla) or fixed for immunohistochemistry (IHC). ANG II increased mean arterial pressure by 40 mmHg, urine Na(+) by 1.67-fold, and urine volume by 3-fold, evidence for hypertension and pressure natriuresis. Na(+) transporters' abundance and activation [assessed by phosphorylation (-P) or proteolytic cleavage] were measured by immunoblot. During ANG II infusion Na(+)/H(+) exchanger 3 (NHE3) abundance decreased in both cortex and medulla; Na-K-2Cl cotransporter 2 (NKCC2) decreased in medullary thick ascending loop of Henle (TALH) and increased, along with NKCC2-P, in cortical TALH; Na-Cl cotransporter (NCC) and NCC-P increased in the distal convoluted tubule; and epithelial Na(+) channel subunits and their cleaved forms were increased in both cortex and medulla. Like NKCC2, STE20/SPS1-related proline alanine-rich kinase (SPAK) and SPAK-P were decreased in medulla and increased in cortex. By IHC, during ANG II NHE3 remained localized to proximal tubule microvilli at lower abundance, and the differential regulation of NKCC2 and NKCC2-P in cortex versus medulla was evident. In summary, ANG II infusion increases Na(+) transporter abundance and activation from cortical TALH to medullary collecting duct while the hypertension drives a natriuresis response evident as decreased Na(+) transporter abundance and activation from proximal tubule through medullary TALH.
血管紧张素 II(ANG II)依赖性高血压时,ANG II 刺激钠(Na+)转运体活性,而高血压抑制其活性,以平衡 Na+输出与输入。本研究旨在验证假说,即 ANG II 输注激活远端肾单位的 Na+转运体,而抑制近段肾单位的 Na+转运体。雄性 Sprague-Dawley 大鼠输注 ANG II(400ng·kg-1·min-1)或载体 2 周。分离肾脏(皮质与髓质)或固定用于免疫组化(IHC)。ANG II 使平均动脉压升高 40mmHg,尿钠增加 1.67 倍,尿量增加 3 倍,提示发生高血压和压力性利尿。通过免疫印迹测量 Na+转运体的丰度和激活(通过磷酸化(-P)或蛋白水解切割来评估)。ANG II 输注时,NHE3 在皮质和髓质中的丰度均下降;NKCC2 在髓质厚升支袢Henle(TALH)中下降,在皮质 TALH 中增加,同时 NKCC2-P 增加;NCC 和 NCC-P 在远曲小管中增加;上皮 Na+通道亚基及其切割形式在皮质和髓质中均增加。与 NKCC2 相似,STE20/SPS1 相关脯氨酸-丙氨酸丰富丝氨酸/苏氨酸激酶(SPAK)和 SPAK-P 在髓质中减少,在皮质中增加。通过 IHC,ANG II 时 NHE3 仍在近端小管微绒毛中定位,但其丰度较低,NKCC2 和 NKCC2-P 在皮质与髓质中的差异调节是明显的。总之,ANG II 输注增加了从皮质 TALH 到髓质集合管的 Na+转运体的丰度和活性,而高血压导致从近端小管到髓质 TALH 的 Na+转运体丰度和活性降低,从而促进利尿。